1O49
CRYSTAL STRUCTURE OF SH2 IN COMPLEX WITH RU85493.
Summary for 1O49
Entry DOI | 10.2210/pdb1o49/pdb |
Descriptor | PROTO-ONCOGENE TYROSINE-PROTEIN KINASE SRC, {4-[2-ACETYLAMINO-2-(1-BIPHENYL-4-YLMETHYL-2-OXO-AZEPAN-3-YLCARBAMOYL)-ETHYL]-2-PHOSPHONO-PHENOXY}-ACETIC ACID (3 entities in total) |
Functional Keywords | sh2 domain fragment approach, signaling protein |
Biological source | Homo sapiens (human) |
Cellular location | Cell membrane: P12931 |
Total number of polymer chains | 1 |
Total formula weight | 13012.58 |
Authors | Lange, G.,Loenze, P.,Liesum, A. (deposition date: 2003-06-15, release date: 2004-02-17, Last modification date: 2023-08-16) |
Primary citation | Lange, G.,Lesuisse, D.,Deprez, P.,Schoot, B.,Loenze, P.,Benard, D.,Marquette, J.P.,Broto, P.,Sarubbi, E.,Mandine, E. Requirements for specific binding of low affinity inhibitor fragments to the SH2 domain of (pp60)Src are identical to those for high affinity binding of full length inhibitors. J.Med.Chem., 46:5184-5195, 2003 Cited by PubMed: 14613321DOI: 10.1021/jm020970s PDB entries with the same primary citation |
Experimental method | X-RAY DIFFRACTION (1.7 Å) |
Structure validation
Download full validation report